Old Drugs as New Treatments for Neurodegenerative Diseases

Pharmaceuticals
Fernando DurãesEmília Sousa

Abstract

Neurodegenerative diseases are increasing in number, given that the general global population is becoming older. They manifest themselves through mechanisms that are not fully understood, in many cases, and impair memory, cognition and movement. Currently, no neurodegenerative disease is curable, and the treatments available only manage the symptoms or halt the progression of the disease. Therefore, there is an urgent need for new treatments for this kind of disease, since the World Health Organization has predicted that neurodegenerative diseases affecting motor function will become the second-most prevalent cause of death in the next 20 years. New therapies can come from three main sources: synthesis, natural products, and existing drugs. This last source is known as drug repurposing, which is the most advantageous, since the drug’s pharmacokinetic and pharmacodynamic profiles are already established, and the investment put into this strategy is not as significant as for the classic development of new drugs. There have been several studies on the potential of old drugs for the most relevant neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Multiple Sc...Continue Reading

References

Dec 26, 1992·Annals of the New York Academy of Sciences·L F AgnatiI Zini
Aug 1, 1992·Acta Physiologica Scandinavica·L F AgnatiK Fuxe
Jan 1, 1982·Acta Neurologica Scandinavica·R A RoosE A van der Velde
May 1, 1994·Neurology·U BonuccelliA Muratorio
Jun 2, 2001·The New England Journal of Medicine·L P Rowland, N A Shneider
Jan 31, 2002·Annual Review of Medicine·Paul RichardsonKenneth Anderson
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·TracyAnn PerryNigel H Greig
May 25, 2002·Acta Neurologica Scandinavica·D PaleacuN Giladi
Dec 31, 2002·Lancet·Hans-Peter HartungUNKNOWN Mitoxantrone in Multiple Sclerosis Study Group (MIMS)
May 21, 2003·Biochemistry·Scott C Hartsel, Theodore R Weiland
Oct 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·William J NetzerPaul Greengard
Feb 14, 2004·Journal of the American Geriatrics Society·Mark B LoebMax Chernesky
Apr 20, 2004·European Journal of Pharmacology·Wei-Qin ZhaoDaniel L Alkon
Apr 20, 2004·European Journal of Pharmacology·G Stennis Watson, Suzanne Craft
Aug 3, 2004·Nature Reviews. Drug Discovery·Ted T Ashburn, Karl B Thor
Sep 10, 2004·Journal of Neural Transmission. Supplementum·A BeisterM Gerlach
Dec 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Bin ZhangJohn Q Trojanowski
Dec 31, 2005·Psychosomatics·Menekse Alpay, Walter J Koroshetz
Mar 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S ZoccolellaUNKNOWN SLAP registry
Oct 30, 2007·The Journal of Clinical Investigation·Jun WangGiulio Maria Pasinetti
Feb 26, 2008·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Kevin DuffJane S Paulsen
Jun 19, 2008·Annual Review of Neuroscience·Bruce D Trapp, Klaus-Armin Nave
Nov 7, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yun DingGuo-Huang Fan
Jan 16, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Frank TippmannFalk Fahrenholz
Jan 23, 2009·Journal of Alzheimer's Disease : JAD·Wei ZhaoGiulio M Pasinetti
Mar 10, 2009·Bioorganic & Medicinal Chemistry·Nicholas W SmithSergei V Dzyuba
Jun 13, 2009·Current Alzheimer Research·K ShudoN Yamagata
Mar 5, 2010·Neurology·F BarkhofUNKNOWN MN166-001 Investigators
Apr 29, 2010·Neuroscience·A M SmithM Dragunow

❮ Previous
Next ❯

Citations

Jan 10, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Giulia AlfediAlessandra Rufini
Feb 19, 2019·Journal of Drug Targeting·Badar Ul IslamShams Tabrez
Apr 27, 2019·Expert Review of Clinical Pharmacology·Luisa SeguellaGiuseppe Esposito
Apr 25, 2019·International Journal of Molecular Sciences·Thais A SalesTeodorico C Ramalho
Oct 4, 2019·BioFactors·Hossein BagheriAmirhossein Sahebkar
Sep 14, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Amira NamsiGérard Lizard
Aug 21, 2019·BioFactors·Shahla KoraniAmirhossein Sahebkar
Apr 12, 2020·Journal of Clinical Medicine·Mehdi Sharifi-RadJavad Sharifi-Rad
Jun 18, 2020·Pharmaceutics·Maria Inês TeixeiraDimitrios A Lamprou
Sep 27, 2018·BMC Pharmacology & Toxicology·Rezvan Enteshari NajafabadiSaeed Nazifi
Sep 19, 2018·Brain Sciences·Rashad HussainMuhammad Shahab
Apr 17, 2020·Frontiers in Neuroscience·Vignayanandam Ravindernath MuddapuM Michael Gromiha
Apr 14, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Rakesh Kumar Singh
Apr 18, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Congcong ZhangAndrea L J Marschall
Apr 23, 2020·Frontiers in Bioengineering and Biotechnology·Seyed Zachariah MoradiMohammad Abdollahi
Apr 4, 2019·Frontiers in Molecular Neuroscience·Bindu D Paul, Solomon H Snyder
Oct 23, 2020·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Zaynab ShakkourFiras Kobeissy
Nov 4, 2020·Archives of Physiology and Biochemistry·Ömer Faruk KalkanZafer Şahin
Jan 24, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Smrithi PadmakumarBenjamin S Bleier
Nov 17, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amna AkhtarMuhammad Yar
Feb 12, 2021·The Journal of Physical Chemistry. B·Shira Ben-Shushan, Yifat Miller
Dec 24, 2019·International Journal of Biological Macromolecules·Chandrasekaran MurugesanMuralitharan Gangatharan
Nov 17, 2020·Frontiers in Bioengineering and Biotechnology·Mariafrancesca CascioneRosaria Rinaldi
Feb 23, 2021·Asian Journal of Pharmaceutical Sciences·Panoraia I SiafakaEvren Atlıhan Gündoğdu
Mar 7, 2021·Chemistry and Physics of Lipids·Sara García-ViñualesDanilo Milardi
Aug 28, 2020·Neurochemistry International·Dia AdvaniPravir Kumar
Mar 31, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Yasmin FardghassemiJ Alex Parker
Jun 4, 2021·Journal of Biomolecular Structure & Dynamics·Suman ManandharK Sreedhara Ranganath Pai
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kanchan BhardwajKamil Kuča

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02953665

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.